The legacy of Viagra, and its creator copyright, presents a challenging case study for investors. Originally a blockbuster drug, generating billions in sales , its patent expiration created a deluge of lower-priced alternatives , significantly eroding its dominance. While some firms may attempt to capitalize on similar conditions , the present land